QUADRANT CAPITAL GROUP LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 139 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$31,720
-10.0%
793
-1.2%
0.00%
-33.3%
Q1 2024$35,260
-44.4%
803
-21.7%
0.00%
-40.0%
Q4 2023$63,459
+71.8%
1,026
+27.8%
0.01%
+25.0%
Q3 2023$36,930
-21.8%
803
-2.3%
0.00%
-20.0%
Q2 2023$47,241
+55.1%
822
+1.2%
0.01%
+66.7%
Q1 2023$30,450
+261.0%
812
+169.8%
0.00%
+200.0%
Q4 2022$8,434
-23.3%
301
-25.5%
0.00%0.0%
Q3 2022$11,000
+37.5%
404
+78.0%
0.00%0.0%
Q2 2022$8,000
-42.9%
227
-42.4%
0.00%
-50.0%
Q1 2022$14,000
+133.3%
394
+60.8%
0.00%
+100.0%
Q4 2021$6,000
-14.3%
245
-31.2%
0.00%0.0%
Q3 2021$7,000
+250.0%
356
+229.6%
0.00%
Q2 2021$2,0000.0%108
-8.5%
0.00%
Q1 2021$2,000
+100.0%
118
+114.5%
0.00%
Q4 2020$1,0000.0%550.0%0.00%
Q3 2020$1,0000.0%550.0%0.00%
Q2 2020$1,0000.0%550.0%0.00%
Q1 2020$1,000
-98.1%
55
-97.9%
0.00%
-100.0%
Q2 2019$54,000
+1.9%
2,6360.0%0.01%0.0%
Q1 2019$53,0002,6360.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 11,961$219,0000.13%
FEDERATED HERMES, INC. 3,441,367$63,046,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 54,751$1,003,0000.11%
GSA CAPITAL PARTNERS LLP 34,425$631,0000.10%
First Trust Direct Indexing L.P. 11,913$218,0000.06%
Summit Global Investments 47,546$871,0000.06%
WINTON GROUP Ltd 49,766$912,0000.05%
FULLER & THALER ASSET MANAGEMENT, INC. 397,950$7,290,0000.05%
AIGEN INVESTMENT MANAGEMENT, LP 16,077$295,0000.04%
EXCHANGE TRADED CONCEPTS, LLC 52,334$959,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders